Pharmaceutical industry
India's Indus Biotech is set to initiate Phase I clinical trials for its anti-HIV and anti-swine flu molecules in the next 3-4 months. The company has filed an investigative new drug (IND) application for its anti-HIV drug with the US FDA and has received approval to conduct Phase
Pharmaceutical industry
As the healthcare sector continues to drive innovation, biotech stocks are being closely watched by investors. On October 13, 2009, Shire plc, a global specialty biopharmaceutical company, announced the settlement of all pending litigation with Sandoz, Inc. regarding the marketing of generic versions of Shire's ADDERALL XR(R)
Pharmaceutical industry
BioMedReports.com, a news portal that covers the biomedical sector and delivers financial and investment intelligence to a community of informed investors, has updated its calendar database with healthcare stock news and upcoming FDA approvals and decisions. The database, featuring over 1,000 healthcare stocks and exchange-traded funds, provides detailed
Pharmaceutical industry
Patients with high cholesterol receiving ISIS 301012, an antisense drug, achieved rapid and prolonged reductions in bad cholesterol, low density lipoprotein (LDL), and triglyceride levels. According to initial data from a phase 2 clinical trial, ISIS 301012 was well tolerated and showed significant reductions in apoB-100, LDL, total cholesterol, and
Pharmaceutical industry
Astex Therapeutics has announced the approval of its Investigational New Drug (IND) application for the clinical development of its proprietary Aurora Kinase inhibitor, AT9283, for the treatment of cancer. This second IND approval in less than 12 months marks a significant milestone for the company, which has been leveraging its
Pharmaceutical industry
A large-scale placebo-controlled study, RUTH, has investigated the effect of a 60 mg daily dose of raloxifene HCl on the risk of coronary events and invasive breast cancer in postmenopausal women with known heart disease or at high risk for heart attack. The study included over 10,000 women from
Pharmaceutical industry
A long-term clinical trial by Generex Biotechnology Corporation has demonstrated the efficacy of its oral insulin spray, Generex Oral-lyn, in improving metabolic control in adolescents and young adults with Type 1 diabetes mellitus. The study showed that replacing one daily subcutaneous injection of regular insulin with Generex Oral-lyn during the
Pharmaceutical industry
Pharmaceutical firm AstraZeneca is conducting trials of a new lung cancer drug in China as part of a worldwide research effort. The trial aims to compare the efficacy and safety of the drug, known as Iressa, in treating late-stage non-small cell lung cancer (NSCLC) patients with established drugs. Iressa has
Pharmaceutical industry
DiObex, Inc. has announced the initiation of a clinical trial to evaluate the safety and pharmacokinetics of DIO-902, a cortisol synthesis inhibitor, in patients with type 2 diabetes. The 2-week trial will assess the effects of three different dose levels of DIO-902 on glucose levels, blood pressure, and cholesterol. According
Drugs
In a significant development in the treatment of prostate cancer, Gloucester Pharmaceuticals, Inc. announced encouraging interim data from its phase 2 clinical study investigating the use of depsipeptide in treating patients with metastatic hormone refractory prostate cancer (HRPC). The data were presented at the American Society of Clinical Oncology (ASCO)
Drugs
Arena Pharmaceuticals, Inc. (ARNA) announced that Ortho-McNeil, Inc., a Johnson & Johnson company, has initiated a phase I clinical trial of APD668, a novel orally administered drug candidate discovered by Arena for the treatment of Type 2 diabetes. This milestone payment triggers a $5 million payment to Arena under its
United States. Food and Drug Administration
A promising new drug, maraviroc, has shown encouraging results in early-stage clinical trials for the treatment of HIV/AIDS. Presented at the 3rd International AIDS Society Conference on Pathogenesis and Treatment, the research indicates that maraviroc is well-tolerated and significantly decreases patient levels of HIV in asymptomatic patients. This investigational
